Pulmonx Corporation (LUNG)
NASDAQ: LUNG · IEX Real-Time Price · USD
7.72
+0.11 (1.45%)
At close: May 1, 2024, 4:00 PM
8.46
+0.74 (9.59%)
Pre-market: May 2, 2024, 4:13 AM EDT

Pulmonx Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021202020192018
Market Capitalization
2984883151,1812,462--
Market Cap Growth
-54.88%-73.31%-52.01%---
Enterprise Value
2224131981,0282,257-729
PE Ratio
-8.03-8.03-5.35-24.28-76.38--
PS Ratio
4.337.115.8824.4075.21--
PB Ratio
2.514.132.056.1110.89--
P/FCF Ratio
-12.71-12.71-6.80-26.22-78.05--
P/OCF Ratio
-12.99-12.99-7.00-28.54-80.37--
EV/Sales Ratio
3.236.013.7021.2268.96-0.201.47
EV/EBITDA Ratio
-7.81-7.81-3.71-23.22-83.960.39-1.88
EV/EBIT Ratio
-7.23-7.23-3.45-21.64-78.280.36-1.85
EV/FCF Ratio
-10.74-10.74-4.28-22.81-71.560.30-1.58
Debt / Equity Ratio
0.350.350.160.140.12-0.12-0.20
Debt / EBITDA Ratio
-0.78-0.78-0.46-0.60-1.01-1.30-2.14
Debt / FCF Ratio
-1.08-1.08-0.53-0.59-0.86-1.02-1.80
Quick Ratio
5.595.598.1110.6518.842.390.88
Current Ratio
6.506.509.1411.8519.962.901.40
Asset Turnover
0.360.360.260.200.210.95-
Interest Coverage
-17.65-17.65-53.94-57.28-9.07-7.78-6.33
Return on Equity (ROE)
-46.60%-46.60%-35.10%-23.70%-166.30%11.70%-
Return on Assets (ROA)
-32.10%-32.10%-28.30%-19.70%-20.30%-60.40%-
Return on Capital (ROIC)
-38.77%-38.77%-32.87%-21.53%-12.76%10.77%11.26%
Earnings Yield
-20.45%-12.46%-18.68%-4.12%-1.31%--
FCF Yield
-12.91%-7.87%-14.71%-3.81%-1.28%--
Buyback Yield / Dilution
-2.37%-2.37%-2.68%-254.74%-473.44%-6.05%-
Total Shareholder Return
-2.37%-2.37%-2.68%-254.74%-473.44%-6.05%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).